Unibest

Pharmaceutical intermediates

Crisaborole Intermediates

4 pharmaceutical intermediates for Crisaborole. Indication: Atopic Dermatitis.

提交项目All intermediates

About Crisaborole

Originator
Anacor Pharmaceuticals Inc
Indication
Atopic Dermatitis
Approved Date
12/14/2016
DS/DP
02/16/2027

Available intermediates

4 intermediates currently listed for Crisaborole. Request specifications, documentation or a quotation for any item below.

Crisaborole intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
2-BROMO-5-HYDROXYBENZALDEHYDE2973-80-0//
4-(4-Bromo-3-formyl-phenoxy)-benzonitrile906673-54-9//
4-[4-bromo-3-(hydroxymethyl)phenoxy]benzonitrile906673-45-8//
[2-bromo-5-(4-cyanophenoxy)phenyl]methyl acetate2227126-09-0//

Other programs under C

Cabozantinib S-malateCalcipotriolCalcitriolCamlipixantCanagliflozinCangrelor TetrasodiumCapivasertib Capmatinib Hydrochloride

Building toward Crisaborole?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →